Detalhe da pesquisa
1.
Myelin Oligodendrocyte Glycoprotein Antibodies in Adults with a First Demyelinating Event Suggestive of Multiple Sclerosis.
Ann Neurol
; 2023 Sep 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37705507
2.
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study.
J Neurol Neurosurg Psychiatry
; 95(2): 142-150, 2024 Jan 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37775266
3.
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 95(5): 410-418, 2024 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37940409
4.
Optic nerve topography in multiple sclerosis diagnostic criteria: Existing knowledge and future directions.
Mult Scler
; 30(2): 139-149, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38243584
5.
Artificial intelligence applied to MRI data to tackle key challenges in multiple sclerosis.
Mult Scler
; 30(7): 767-784, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38738527
6.
Efficacy and safety results after >3.5 years of treatment with the Bruton's tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study.
Mult Scler
; 30(4-5): 558-570, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38436271
7.
A wearable device perspective on the standard definitions of disability progression in multiple sclerosis.
Mult Scler
; 30(1): 103-112, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38084497
8.
Prediction of disease activity and treatment failure in relapsing-remitting MS patients initiating daily oral DMTs.
Mult Scler
; 30(7): 820-832, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38551315
9.
Association of magnetic resonance imaging phenotypes and serum biomarker levels with treatment response and long-term disease outcomes in multiple sclerosis patients.
Eur J Neurol
; 31(1): e16077, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37754568
10.
Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury.
Clin Chem Lab Med
; 62(2): 322-331, 2024 Jan 26.
Artigo
Inglês
| MEDLINE | ID: mdl-37702323
11.
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
N Engl J Med
; 383(6): 546-557, 2020 08 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32757523
12.
Increased cytomegalovirus immune responses at disease onset are protective in the long-term prognosis of patients with multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 94(3): 173-180, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36344261
13.
Characterisation of the safety profile of evobrutinib in over 1000 patients from phase II clinical trials in multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus: an integrated safety analysis.
J Neurol Neurosurg Psychiatry
; 94(1): 1-9, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36418156
14.
Spinal cord reserve in multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 94(7): 502-510, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36690430
15.
Global and Regional Deep Learning Models for Multiple Sclerosis Stratification From MRI.
J Magn Reson Imaging
; 2023 Oct 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37803817
16.
Antibody response to SARS-CoV-2 vaccines in patients with relapsing multiple sclerosis treated with evobrutinib: A Bruton's tyrosine kinase inhibitor.
Mult Scler
; 29(11-12): 1471-1481, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37626477
17.
Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study.
Mult Scler
; 29(6): 719-730, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37012898
18.
Improvements in quality of life over 2 years with cladribine tablets in people with relapsing multiple sclerosis: The CLARIFY-MS study.
Mult Scler
; 29(14): 1808-1818, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37978852
19.
Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community.
Mult Scler
; 29(11-12): 1363-1372, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37691493
20.
A single-dose strategy for immunization with live attenuated vaccines is an effective option before treatment initiation in multiple sclerosis patients.
Mult Scler
; 29(14): 1841-1848, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37728389